Axa’s Abbott ABT Stock Holding History

Axa’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,200,987	Closed	-$163M	–	69
2025 Q2	$163M	Buy	1,200,987 +83,425	+7%	+$11M	0.47%	42
2025 Q1	$148M	Buy	1,117,562 +8,028	+0.7%	+$1.02M	0.49%	45
2024 Q4	$125M	Sell	1,109,534 -312,735	-22%	-$36.1M	0.38%	52
2024 Q3	$162M	Buy	1,422,269 +38,844	+3%	+$4.26M	0.48%	36
2024 Q2	$144M	Buy	1,383,425 +605,269	+78%	+$64.2M	0.43%	42
2024 Q1	$88.4M	Sell	778,156 -636,734	-45%	-$73M	0.27%	83
2023 Q4	$156M	Sell	1,414,890 -109,281	-7%	-$10.9M	0.5%	40
2023 Q3	$148M	Buy	1,524,171 +58,985	+4%	+$6.2M	0.52%	37
2023 Q2	$160M	Sell	1,465,186 -227,551	-13%	-$24.3M	0.53%	35
2023 Q1	$171M	Buy	1,692,737 +191,861	+13%	+$20.3M	0.59%	31
2022 Q4	$165M	Buy	1,500,876 +58,321	+4%	+$6.04M	0.59%	29
2022 Q3	$140M	Buy	1,442,555 +186,669	+15%	+$19.9M	0.55%	29
2022 Q2	$136M	Buy	1,255,886 +126,093	+11%	+$14.3M	0.51%	38
2022 Q1	$134M	Buy	1,129,793 +32,644	+3%	+$4.05M	0.38%	54
2021 Q4	$154M	Buy	1,097,149 +44,693	+4%	+$5.72M	0.39%	56
2021 Q3	$124M	Sell	1,052,456 -821	-0.1%	-$101K	0.35%	64
2021 Q2	$122M	Sell	1,053,277 -61,578	-6%	-$7.18M	0.34%	64
2021 Q1	$134M	Sell	1,114,855 -61,955	-5%	-$7.34M	0.41%	50
2020 Q4	$129M	Buy	1,176,810 +266,569	+29%	+$29M	0.4%	49
2020 Q3	$99.1M	Buy	910,241 +232,600	+34%	+$23.6M	0.36%	58
2020 Q2	$62M	Buy	677,641 +151,168	+29%	+$13.7M	0.24%	102
2020 Q1	$41.5M	Buy	526,473 +54,800	+12%	+$4.57M	0.21%	118
2019 Q4	$41M	Buy	471,673 +10,569	+2%	+$885K	0.17%	155
2019 Q3	$38.6M	Buy	461,104 +41,335	+10%	+$3.51M	0.15%	177
2019 Q2	$35.3M	Buy	419,769 +139,073	+50%	+$10.9M	0.14%	204
2019 Q1	$22.4M	Buy	280,696 +41,203	+17%	+$3.07M	0.09%	276
2018 Q4	$17.3M	Sell	239,493 -108	-0%	-$7.59K	0.08%	302
2018 Q3	$17.6M	Buy	239,601 +4,076	+2%	+$268K	0.06%	327
2018 Q2	$14.4M	Sell	235,525 -38,000	-14%	-$2.3M	0.06%	348
2018 Q1	$16.4M	Buy	273,525 +14,099	+5%	+$850K	0.07%	334
2017 Q4	$14.8M	Sell	259,426 -274,637	-51%	-$15.2M	0.06%	358
2017 Q3	$28.5M	Sell	534,063 -685,802	-56%	-$34.4M	0.12%	220
2017 Q2	$59.3M	Buy	1,219,865 +295,419	+32%	+$13.4M	0.27%	99
2017 Q1	$41.1M	Sell	924,446 -702,794	-43%	-$30.4M	0.19%	161
2016 Q4	$62.5M	Buy	1,627,240 +974,540	+149%	+$38.6M	0.29%	95
2016 Q3	$27.6M	Sell	652,700 -1,025,400	-61%	-$43.9M	0.12%	215
2016 Q2	$66M	Buy	1,678,100 +1,406,600	+518%	+$56M	0.29%	92
2016 Q1	$11.4M	Sell	271,500 -21,400	-7%	-$848K	0.05%	364
2015 Q4	$13.2M	Sell	292,900 -6,922	-2%	-$306K	0.06%	323
2015 Q3	$12.1M	Sell	299,822 -23,702	-7%	-$1.12M	0.05%	336
2015 Q2	$15.9M	Sell	323,524 -9,507	-3%	-$456K	0.06%	296
2015 Q1	$15.4M	Sell	333,031 -621,328	-65%	-$28.5M	0.06%	310
2014 Q4	$43M	Sell	954,359 -25,293	-3%	-$1.1M	0.17%	158
2014 Q3	$40.7M	Buy	979,652 +527,118	+116%	+$22.3M	0.17%	164
2014 Q2	$18.5M	Buy	452,534 +67,077	+17%	+$2.63M	0.08%	281
2014 Q1	$14.8M	Sell	385,457 -228,351	-37%	-$8.8M	0.06%	301
2013 Q4	$23.5M	Sell	613,808 -8,230	-1%	-$303K	0.11%	219
2013 Q3	$20.6M	Buy	622,038 +99,431	+19%	+$3.49M	0.1%	230
2013 Q2	$18.2M	Buy	+522,607	New	+$19.2M	0.1%	228

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Axa's ABT Position: Q3 2025 in Review

Axa sold out of Abbott (ABT) in Q3 2025, closing a stake of 1,200,987 shares — an estimated $163M sold.

Axa first reported a position in ABT in Q2 2013 and held it in 49 quarters. The position peaked at $171M in Q1 2023. 3,173 funds tracked by Wall St. Rank hold ABT as of Q3 2025.

Axa reported no remaining Abbott position as of Q3 2025 after selling out during the quarter.
Axa sold 1,200,987 Abbott shares in Q3 2025, an estimated $163M.
Axa first reported a position in Abbott in Q2 2013 and held it in 49 quarters.
Axa's Abbott position peaked at $171M in Q1 2023.
3,173 funds tracked by Wall St. Rank held Abbott as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.